Bio-Rad Laboratories, Inc. (BIO) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $355.23 --0%
Financial Fact:
Income from operations: 22.53M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Income from operations: 22.53M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) reported Q1 EPS of $1.16, $0.16 worse than the analyst estimate of $1.32. Revenue for the quarter came in at $485.1 million versus the consensus estimate of $482.11 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VNET Group (VNET) Misses Q2 EPS by 164c
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc. (XP) Tops Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
